Kiichiro Ninomiya

9PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in patients with locally advanced NSCLC.

|Jan 13, 2026
Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study.

Tadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi

|Oct 21, 2025
Remarkable response of gastric adenocarcinoma with FGFR2-TRIM44 fusion to pemigatinib: a case report.

Miho Fujiwara, Kiichiro Ninomiya, Emi Chikuie

|May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation.

Sachi Okawa, Shuta Tomida, Tadahiro Kuribayashi

|May 06, 2025
Efficacy and safety of cancer vaccine therapy in malignant melanoma: a systematic review.

Takeshi Seta, Shohei Nakamura, Mitsuaki Oura

|Jan 06, 2025
Successful immunotherapy with ipilimumab and nivolumab in a patient with pulmonary sclerosing pneumocytoma.

Yumi Inukai-Motokura, Kiichiro Ninomiya, Takahiro Baba

Pageof 2

Frequent Collaborators

4 joint publications

Katuyuki Hotta

4 joint publications

Eiki Ichihara

4 joint publications

Go Makimoto

3 joint publications

Kadoaki Ohashi